sector: Healthcare ·
industry: Biotechnology ·
As of
26 Nov 2009
58.40CHF
CHF58.40
26 Nov 2009
-2.01%
CHF59.60
CHF59.30
302,006
CHF59.50
CHF58.15
CHF66.40
CHF47.66
0.48
334,330
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Cawthorn, Robert |
Chairman of the Board of Directors |
85,293 |
| Clozel, Jean-Paul |
Member of the Executive Committee, Chief Executive Officer, Delegate to Board of Directors |
5,216,430 |
| Buckingham, Simon |
Member of the Executive Committee, President Corporate and Business Development |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
CHF7,116.03 |
| Shares Outstanding (Mil.) |
119.40 |
| Float (Mil.) |
105.00 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (CHF CHF) |
-- |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
1.57 |
| Current Ratio |
2.07 |
| LT Debt/Equity |
0.00 |
| Total Debt/Equity |
29.38 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
17.73 |
| Price/Sales(TTM) |
4.17 |
| Price/Book(TTM) |
4.95 |
| Price/Cash Flow(TTM) |
15.26 |
| |
|
| Per Share Data |
| Earnings(TTM) |
CHF3.45 |
| Sales(TTM) |
CHF14.02 |
| Book Value(MRQ) |
CHF12.05 |
| Cash Flow(TTM) |
CHF3.83 |
| Cash(MRQ) |
CHF10.78 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
37.10 |
| Return on Assets(TTM) |
18.04 |
| Return on Investment(TTM) |
29.28 |
| |
|
| Margins |
| Gross Margin(TTM) % |
88.94 |
| Operating Margin(TTM) % |
26.92 |
| Profit Margin(TTM) % |
24.00 |
|
| |
|